Literature DB >> 881264

Influenza immunization: serologic and clinical responses in military units.

N Egoz, B Morag, W Klingberg, R Chen, M A Klingberg.   

Abstract

Two inactivated influenza-virus vaccines were tested and compared in three army training units in Israel. The serological responses to the vaccines and the side-effects were assessed. The vaccines contained the influenza strains which were prevalent in 1974: A2/Port Chalmers/1/73 and B/Hong Kong/8/73. One of the vaccines also contained A2/England/42/72. Both vaccines caused a more than three-fold rise in geometric mean titers against influenza A strains, and about a twofold rise in geometric mean titers against influenza B/Hong Kong/5/73. Approximately 75%-80% of the vaccinees acquired protective hemagglutination-inhibition antibody titers against influenza A strains, while less than 30% acquired protective titers against B strains. In general, there were no significant differences between the serological responses to the two vaccines. More than 50% of the vaccinees experienced at least one systemic side-effect (50.3% with one vaccine and 61.0% with the other). The average number of side-effects per person was between 1.78 and 2.11. However, these side-effects were generally of short duration and caused minimal disability. On the whole, the two vaccines did not differ significantly with regard to the side-effects they caused.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 881264     DOI: 10.1007/bf01642083

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Influenza immunization: field trial on a university campus.

Authors:  R H Waldman; W J Coggins
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

2.  Effect of two doses of influenza vaccine in stimulating antibody in volunteers.

Authors:  C H Howells; A D Evans; C Vesselinova-Jenkins
Journal:  Lancet       Date:  1973-06-23       Impact factor: 79.321

3.  A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines.

Authors:  A S Beare; D Hobson; S E Reed; D A Tyrrell
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

4.  Antibody response and reactions to aqueous influenza vaccine, simple emulsion vaccine and multiple emulsion vaccine. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.

Authors:  P J Taylor; C L Miller; T M Pollock; F T Perkins; M A Westwood
Journal:  J Hyg (Lond)       Date:  1969-09

5.  Purified influenza virus vaccine. A study of viral reactivity and antigenicity.

Authors:  F B Peck
Journal:  JAMA       Date:  1968-12-02       Impact factor: 56.272

6.  Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man.

Authors:  S R Mostow; S C Schoenbaum; W R Dowdle; M T Coleman; H S Kaye; J C Hierholzer
Journal:  Am J Epidemiol       Date:  1970-10       Impact factor: 4.897

7.  Influenza immunization and lost time in industry.

Authors:  J F Coyne
Journal:  J Occup Med       Date:  1969-06

8.  Antigenic response to influenza virus in man. II. Neutralizing antibody response to inactivated monovalent B vaccine, with observations on vaccine efficacy during a subsequent type B epidemic.

Authors:  P Brown; D C Gajdusek; K M Chen; J A Morris
Journal:  Am J Epidemiol       Date:  1969-10       Impact factor: 4.897

9.  Antigenic response to influenza virus in man. I. Neutralizing antibody response to inactivated monovalent A2 vaccine as related to prior influenza exposure.

Authors:  P Brown; D C Gajdusek; J A Morris
Journal:  Am J Epidemiol       Date:  1969-10       Impact factor: 4.897

  9 in total
  1 in total

1.  Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Nicolas C Issa; Francisco M Marty; Lisa S Gagne; Sophia Koo; Kelly A Verrill; Edwin P Alyea; Corey S Cutler; John Koreth; Philippe Armand; Vincent T Ho; Joseph H Antin; Robert J Soiffer; Lindsey R Baden
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-13       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.